School of Graduate Studies
Dr. Memiah holds the position of Professor at the University of Maryland and serves as the director for both the Implementation and Dissemination Science program and the Global Monitoring and Evaluation program at the Graduate School. Additionally, he is a fellow in the HIV Intervention Science Training Program (HISTP), supported by the National Institutes of Health (NIH). This program aims to nurture and advance scientists engaged in technology-driven research related to HIV dissemination and implementation.
Dr. Memiah has an extensive body of work, with over 100 publications in peer-reviewed journals. He is an accomplished epidemiologist and enjoys international recognition for his expertise in continuous quality improvement. He has worked closely with various national organizations to develop and implement quality improvement (QI) programs, focusing on achieving the best possible outcomes for clients.
Furthermore, Dr. Memiah has taken on leadership roles in planning evaluations for various non-profit, private, and public agencies in a consulting capacity. These include evaluations for entities such as UNICEF (focused on Adolescent and Youth HIV/Sexual Reproductive Health), the Norwegian Lutheran Mission (centered on a health care capacity building project to enhance public health services), the Kenya Ministry of Health (related to the Elimination of Mother to Child Transmission or eMTCT), and the United Nations Trust Fund (on Gender-Based violence).
In his career, he has played a key role in shaping country guidelines, including his contribution to developing the Lesotho Strategic Plan for 2023-2027 and, most recently, the Eswatini National Strategic Framework. Dr. Memiah has also contributed significantly to formulating health policies in various countries. He has acted as the Principal Investigator for several grants that address critical issues in adolescent health and the health workforce and explores the convergence of adolescent health, digital solutions, HIV, and non-communicable diseases globally.